![Darcy Mootz](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Darcy Mootz
Direttore/Membro del Consiglio presso ELEVATION ONCOLOGY, INC.
Patrimonio netto: - $ in data 31/05/2024
Posizioni attive di Darcy Mootz
Società | Posizione | Inizio | Fine |
---|---|---|---|
ELEVATION ONCOLOGY, INC. | Direttore/Membro del Consiglio | 18/01/2024 | - |
Independent Dir/Board Member | 18/01/2024 | - |
Storia della carriera di Darcy Mootz
Precedenti posizioni note di Darcy Mootz
Società | Posizione | Inizio | Fine |
---|---|---|---|
ORIC PHARMACEUTICALS, INC. | Corporate Officer/Principal | 10/08/2016 | - |
Alpha-9 Oncology, Inc.
![]() Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Direttore/Membro del Consiglio | - | - |
ACHAOGEN | Corporate Officer/Principal | - | - |
Formazione di Darcy Mootz
Harvard University | Doctorate Degree |
Duke University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 6 |
Canada | 2 |
Posizioni
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Doctorate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
ORIC PHARMACEUTICALS, INC. | Health Technology |
ELEVATION ONCOLOGY, INC. | Health Technology |
Aziende private | 2 |
---|---|
Achaogen, Inc.
![]() Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA. | Health Technology |
Alpha-9 Oncology, Inc.
![]() Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | Commercial Services |
- Borsa valori
- Insiders
- Darcy Mootz
- Esperienza